American Society of Clinical Oncology, Journal of Oncology Practice, 4(11), p. 267-272, 2015
Full text: Download
Low-dose CT screening is expected to increase lung cancer diagnoses, shift stage at diagnosis toward earlier stages, and increase Medicare expenditures over a 5-year time horizon.